RxDoctor Payments Data

Kazuo Suzuki, DPM

Podiatrist · Beverly Hills, CANPI 1841356888

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,745 of the $57,090 with a category attached, or 81.9%. 38 manufacturers reported payments, led by Avita Medical Americas, LLC at 36.1% of the total. 2025 is the largest year on record at $27,899, more than ten times the $684 reported in 2019. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,090in general payments, 2019–2025

Across 187 payments — averaging $305.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avita Medical Americas, LLC$21K
  • Kaneka Medical America LLC$18K
  • Daiichi Sankyo Inc.$13K
  • Novo Nordisk$2K
  • Paratek Pharmaceuticals, Inc.$878
  • Smith+Nephew$396
  • plus $3K from 32 others

What the payments were for

  • Consulting fees$46,74582%
  • Speaking & faculty fees$3,0005%
  • Travel & lodging$1,6333%
  • Food & beverage$5,2799%
  • Education$1290%
  • Entertainment$3031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,090 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$939,368
Medicare patients
841
Services billed
12,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine1,375$31,433
Diclofenac Sodium15$19,858
Fluconazole1,044$7,828
Linezolid55$4,990
Doxycycline Hyclate386$3,149
Gabapentin286$1,502
Clotrimazole72$1,349
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen87$599
Mupirocin55$497
Tramadol Hcl108$366
Doxycycline Monohydrate23$244
Pregabalin24$203
Levofloxacin38$143
Terbinafine Hcl22$72

Paid to pharmacies, not to this prescriber.

Other podiatrist in Beverly Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →